The gingival crevicular fluid levels of interleukin-11 and interleukin-17 in patients with aggressive periodontitis

Journal of Periodontology

Volumn 83, Issue 11, 2012, Pages 1425-1431

  Ay, Zuhal Yetkin ^a   Yilmaz, Gülin ^a   Özdem, Muhsin ^a   Kocxak, Havva ^b   Sütçü, Recep ^b   Uskun, Ersin ^b   Tonguç, Mine Öztürk ^a   Kirzioǧlu, Fatma Yeşim ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Aggressive periodontitis; Cytokines; Gingival crevicular fluid; Periodontal diseases

Indexed keywords

INTERLEUKIN 11; INTERLEUKIN 17;

ADULT; AGGRESSIVE PERIODONTITIS; ARTICLE; CASE CONTROL STUDY; CHEMISTRY; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NONPARAMETRIC TEST; REPRODUCIBILITY;

ADULT; AGGRESSIVE PERIODONTITIS; CASE-CONTROL STUDIES; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-11; INTERLEUKIN-17; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84868364629     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.110585     Document Type: Article

References (49)

1. Kinane DF. Periodontitis modified by systemic factors. Ann Periodontol 1999;4:54-64.
2. Tonetti MS, Mombelli A. Early-onset periodontitis. Ann Periodontol 1999;4:39-53.
3. Houri-Haddad Y, Wilensky A, Shapira L. T-cell phenotype as a risk factor for periodontal disease. Periodontol 2000 2007;45:67-75.
4. Kramer JM, Gaffen SL. Interleukin-17: A new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007;78:1083-1093.
5. Lubberts E. IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis? Cytokine 2008; 41:84-91.
6. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008;223:87-113.
7. Witowski J, Pawlaczyk K, Breborowicz A, et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 2000;165:5814-5821.
8. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003; 170:2106-2112.
9. Zelante T, De Luca A, Bonifazi P, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007;37: 2695-2706.
10. Lexberg MH, Taubner A, Forster A, et al. Th memory for interleukin-17 expression is stable in vivo. Eur J Immunol 2008;38:2654-2664.
11. Katz Y, Nadiv O, Beer Y. Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: A possible role as a ''fine-tuning cytokine'' in inflammation processes. Arthritis Rheum 2001;44:2176-2184.
12. Nakchbandi IA, Mitnick MA, Masiukiewicz US, Sun BH, Insogna KL. IL-6 negatively regulates IL-11 production in vitro and in vivo. Endocrinology 2001;142:3850- 3856.
13. Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 2005;32:369-374.
14. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995;86:1243- 1254.
15. Du X, Williams DA. Interleukin-11: review of molecular, cell biology, and clinical use. Blood 1997;89:3897- 3908.
16. Curti A, Ratta M, Corinti S, et al. Interleukin-11 induces Th2 polarization of human CD4(+) T cells. Blood 2001; 97:2758-2763.
17. Redlich CA, Gao X, Rockwell S, Kelley M, Elias JA. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 1996; 157:1705-1710.
18. Trepicchio WL, Wang LL, Bozza M, Dorner AJ. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J Immunol 1997; 159:5661-5670.
19. Seymour GJ, Gemmell E. Cytokines in periodontal disease: Where to from here? Acta Odontol Scand 2001;59:167-173.
20. Honda T, Domon H, Okui T, Kajita K, Amanuma R, Yamazaki K. Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clin Exp Immunol 2006;144:35-40.
21. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
22. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21: 533-551.
23. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
24. Johnson RB, Wood N, Serio FG. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol 2004;75:37-43.
25. YucelOO, Berker E, Gariboglu S,Otlu H. Interleukin-11, interleukin-1b, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol 2008;35:365-370.
26. Yetkin Ay Z, Sutcxu R, Uskun E, Bozkurt FY, Berker E. The impact of the IL-11:IL-17 ratio on the chronic periodontitis pathogenesis: A preliminary report. Oral Dis 2009;15:93-99.
27. Martuscelli G, Fiorellini JP, Crohin CC, Howell TH. The effect of interleukin-11 on the progression of ligatureinduced periodontal disease in the beagle dog. J Periodontol 2000;71:573-578.
28. Suga K, Saitoh M, Kokubo S, et al. Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model. J Interferon Cytokine Res 2004;24:343-349.
29. Vernal R, Dutzan N, Chaparro A, Puente J, Antonieta Valenzuela M, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005;32:383-389.
30. Lester SR, Bain JL, Johnson RB, Serio FG. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol 2007;78:1545-1550.
31. Ohyama H, Kato-Kogoe N, Kuhara A, et al. The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res 2009;88:633-638.
32. Allam JP, Duan Y, Heinemann F, et al. IL-23-producing CD68(+) macrophage-like cells predominate within an IL-17-polarized infiltrate in chronic periodontitis lesions. J Clin Periodontol 2011;38:879-886.
33. Beklen A, Ainola M, Hukkanen M, Gurgan C, Sorsa T, Konttinen YT. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 2007;86:347-351.
34. Ito H, Honda T, Domon H, et al. Gene expression analysis of the CD4+ T-cell clones derived from gingival tissues of periodontitis patients. Oral Microbiol Immunol 2005;20:382-386.
35. Cardoso CR, Garlet GP, Crippa GE, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol 2009;24:1-6.
36. Pradeep AR, Hadge P, Chowdhry S, Patel S, Happy D. Exploring the role of Th1 cytokines: Interleukin-17 and interleukin-18 in periodontal health and disease. J Oral Sci 2009;51:261-266.
37. Schenkein HA, Koertge TE, Brooks CN, Sabatini R, Purkall DE, Tew JG. IL-17 in sera from patients with aggressive periodontitis. J Dent Res 2010;89:943-947.
38. Zhao L, Zhou Y, Xu Y, Sun Y, Li L, Chen W. Effect of non-surgical periodontal therapy on the levels of Th17/Th1/Th2 cytokines and their transcription factors in Chinese chronic periodontitis patients. J Clin Periodontol 2011;38:509-516.
39. Duarte PM, da Rocha M, Sampaio E, et al. Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: A pilot study. J Periodontol 2010; 81:1056-1063.
40. Ozcxaka O, Nalbantsoy A, Buduneli N. Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. J Periodontal Res 2011;46:592-598.
41. Garlet GP, Cardoso CR, Campanelli AP, et al. The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: Host protection and tissue destruction. Clin Exp Immunol 2007;147:128-138.
42. Offenbacher S, Scott SS, Odle BM, Wilson-Burrows C, Van Dyke TE. Depressed leukotriene B4 chemotactic response of neutrophils from localized juvenile periodontitis patients. J Periodontol 1987;58:602-606.
43. Palmer GD, Watts TL, Addison IE. A skin window study of neutrophil migration in subjects with localized juvenile periodontitis. J Clin Periodontol 1993;20:452-456.
44. Kimura S, Yonemura T, Hiraga T, Okada H. Flow cytometric evaluation of phagocytosis by peripheral blood polymorphonuclear leucocytes in human periodontal diseases. Arch Oral Biol 1992;37:495-501.
45. Eick S, Pfister W, Sigusch B, Straube E. Phagocytosis of periodontopathogenic bacteria by crevicular granulocytes is depressed in progressive periodontitis. Infection 2000;28:301-304.
46. Yu JJ, Ruddy MJ, Wong GC, et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: Recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007; 109:3794-3802.
47. Kaneyama K, Segami N, Sato J, NishimuraM, Yoshimura H. Interleukin-6 family of cytokines as biochemical markers of osseous changes in the temporomandibular joint disorders. Br J Oral Maxillofac Surg 2004;42:246- 250.
48. Juarranz Y, Abad C, Martinez C, et al. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther 2005;7:R1034-R1045.
49. Kawaguchi M, Fujita J, Kokubu F, et al. IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1- CREB pathway. Am J Physiol Lung Cell Mol Physiol 2009;296:L804-L810.